Skip to main content

Table 1 Demographic data of the population

From: Long-term dyspnea, regional ventilation distribution and peripheral lung function in COVID-19 survivors: a 1 year follow up study

 

No Dyspnea (n = 18)

Dyspnea (n = 15)

Overall population (n = 33)

P value

Age (years)

62 ± 11

66 ± 11

64 ± 11

0.35

Male: Females ratio (N)

12:6

12:3

24:9

0.4

Height (cm)

172 ± 6

174 ± 10

173 ± 8

0.54

Weight (kg)

84 ± 12

88 ± 13

86 ± 13

0.29

BMI (kg/cm2)

28 ± 2.8

29 ± 3.9

28.5 ± 3.3

0.35

Smokers

   

0.14

No, n (%)

14(77.8%)

8 (53.3%)

22/33 (66.7%)

 

Current /Former smokers; n(%)

4 (22.2%)

7 (46.7%)

11/33 (33.3%)

 

COPD/Asthma (No. n(%))

17 (94.4%)

13 (86.7%)

30 (90.9%)

0.53

Admission to intensive care unit (yes)

13 (72.2%)

8 (53.3%)

21 (64%)

0.26

Days of hospital stay (days)

25[14–59]

25[11–40]

24 [13–43]

0.88

Days of ICU stay (days)

13[0–18]

3[0–16]

7[0–18]

0.18

Days of mechanical ventilation (days)

8.7 ± 16

1.5 ± 4.5

5 ± 12

0.09

Highest respiratory support during hospital stay (yes)

   

0.34

Nasal cannula

2 (11%)

5 (33%)

7 (21%)

 

HFNO

2 (11%)

2 (13%)

4 (12%)

 

NIV

8 (44%)

6 (40%)

14 (42%)

 

Endotracheal intubation

6 (33%)

2 (13%)

8 (24%)

 
  1. BMI body mass index, COPD chronic obstructive pulmonary disease, ICU intensive care unit, HFNO high flow nasal oxygen, NIV non invasive ventilation